Featured Research

from universities, journals, and other organizations

Researchers map the global spread of drug-resistant influenza

Date:
September 15, 2011
Source:
University of Florida
Summary:
In the new movie "Contagion," fictional health experts scramble to get ahead of a flu-like pandemic as a drug-resistant virus quickly spreads, killing millions of people within days after they contract the illness. Although the film isn't based entirely on reality, it's not exactly science fiction, either. In a new study, researchers explain how seasonal H1N1 influenza became resistant to oseltamivir, otherwise known as Tamiflu, the most widely used antiviral agent for treating and preventing flu. The scientists say that a combination of genetic mutations and human migration through air travel can lead to the rapid global spread of drug-resistant strains.

3-D graphical representation of a generic influenza virion’s ultrastructure.
Credit: Dan Higgins / Image courtesy of CDC

In the new movie "Contagion," fictional health experts scramble to get ahead of a flu-like pandemic as a drug-resistant virus quickly spreads, killing millions of people within days after they contract the illness.

Although the film isn't based entirely on reality, it's not exactly science fiction, either.

"Certain strains of influenza are becoming resistant to common treatments," said Ira M. Longini, a professor of biostatistics in the University of Florida College of Public Health and Health Professions, the UF College of Medicine, and the UF Emerging Pathogens Institute. "We've been able to map out globally how this phenomenon is happening."

Longini is among a team of researchers who have published this month in the Royal Society journal Interface and explain how seasonal H1N1 influenza became resistant to oseltamivir, otherwise known as Tamiflu, the most widely used antiviral agent for treating and preventing flu. The scientists say that a combination of genetic mutations and human migration through air travel can lead to the rapid global spread of drug-resistant strains.

"If you see resistant strains in parts of the world where no one is taking antiviral drugs, that's the smoking gun that the resistant strain must be transmitting," said Longini, who also worked on this research at the Fred Hutchinson Cancer Research Center in Seattle.

In some situations, drug-resistant bacteria and viruses can spread when drugs are overused. The scientists explored this theory using a mathematical model that simulates the spread of influenza across 321 cities connected by air travel. Using this model, they found that oseltamivir use had not been nearly widespread enough to promote the spread of antiviral resistance after it arose. However, the resistant strain probably originated in one person taking the drug.

"Oseltamivir is an important prophylactic, or preventative agent, against future flu viruses, including a potential H5N1, or 'bird flu,' pandemic," said Dennis Chao, the lead author of the paper and a staff scientist at the Center for Statistics and Quantitative Infectious Diseases at the Fred Hutchinson Cancer Research Center.

However, influenza can mutate, making the drug less effective. It had been believed that this mutation would not spread because it makes the flu less transmissible in people not taking the drug.

"The fact that it spread so quickly in seasonal H1N1 between 2006 and 2008 took everyone by surprise," Chao said.

The researchers say that the mutation may have "hitchhiked" on one or more other mutations that made the drug-resistant influenza strain more transmissible. They suggest that because strains of influenza turn over so rapidly, there are many opportunities for these types of mutations to arise in an otherwise highly transmissible strain and become widespread, and it can become the dominant strain within a couple of years, making the drug useless.

"For the next pandemic, we should have all the available drugs at our disposal as a first line of defense to both prevent infection and to treat the most vulnerable," Longini said. "Or else, the chance that the next pandemic influenza strain is resistant goes up. We know something like 'Contagion' could happen for influenza."

Jesse D. Bloom of the Fred Hutchinson Cancer Research Center, and Beth F. Kochin and Rustom Antia of Emory University are also authors of the paper.


Story Source:

The above story is based on materials provided by University of Florida. The original article was written by Claudia Adrien. Note: Materials may be edited for content and length.


Cite This Page:

University of Florida. "Researchers map the global spread of drug-resistant influenza." ScienceDaily. ScienceDaily, 15 September 2011. <www.sciencedaily.com/releases/2011/09/110914143641.htm>.
University of Florida. (2011, September 15). Researchers map the global spread of drug-resistant influenza. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2011/09/110914143641.htm
University of Florida. "Researchers map the global spread of drug-resistant influenza." ScienceDaily. www.sciencedaily.com/releases/2011/09/110914143641.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins